PCN61 COST-EFFECTIVENESS OF 1-YEAR ADJUVANT TRASTUZUMAB THERAPY FOR EARLY STAGE OF HER2-POSITIVE BREAST CANCER
May 1, 2011, 00:00
10.1016/j.jval.2011.02.916
https://www.valueinhealthjournal.com/article/S1098-3015(11)01055-2/fulltext
Title :
PCN61 COST-EFFECTIVENESS OF 1-YEAR ADJUVANT TRASTUZUMAB THERAPY FOR EARLY STAGE OF HER2-POSITIVE BREAST CANCER
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01055-2&doi=10.1016/j.jval.2011.02.916
First page :
A165
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
389